{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/283417438"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The FDA recommends that patients with end-stage kidney disease who receive erythropoiesis-stimulating drugs should:Maintain hemoglobin levels between 10 - 12 g/dLReceive frequent blood tests to monitor hemoglobin levelsContact their doctors if they experience such symptoms as shortness of breath, pain, swelling in the legs, or increases in blood pressure" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "stlukes-stl.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/4338004"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/283417438" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/28202509"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/283417438"] } } }
